Johnson & Johnson Services Inc Executive and Leadership Team

Joaquin Duato, the Chief Executive Officer at Johnson & Johnson Services Inc, directs the overarching strategic vision for the global healthcare enterprise. Overseeing the integration of pharmaceutical research and medical technology development, the Chief Executive Officer ensures alignment between scientific innovation and market needs. This leadership role involves managing complex portfolios in oncology and immunology to maintain competitive advantages. By prioritizing long-term growth, Joaquin Duato drives the company toward sustainable medical breakthroughs. The Chief Executive Officer collaborates with the Board to refine corporate governance and operational efficiency across all international markets. Through rigorous oversight of resource allocation, the Chief Executive Officer secures the financial health of the organization. Ultimately, Duato shapes the future of healthcare delivery by fostering a culture of excellence and scientific rigor, ensuring the company remains a leader in providing life-saving medicines and advanced surgical products to patients worldwide.

Victor Karam, the Finance Innovative Medicine Chief Financial Officer & Vice President (Asia Pacific) at Johnson & Johnson Services Inc, manages financial planning and fiscal strategy for the pharmaceutical division within the Asia Pacific region. Overseeing regional budget allocation, the Chief Financial Officer & Vice President (Asia Pacific) ensures that innovative medicine initiatives receive necessary funding to penetrate diverse healthcare markets. This leadership role involves analyzing regional economic trends to optimize revenue streams and cost structures. By implementing robust financial controls, Victor Karam drives operational efficiency across the Asia Pacific pharmaceutical portfolio. The Chief Financial Officer & Vice President (Asia Pacific) coordinates with global leadership to align regional performance with corporate growth targets. Through strategic investment in local clinical trials and distribution networks, the Chief Financial Officer & Vice President (Asia Pacific) strengthens the market position of the company. Ultimately, Karam secures the financial stability required to deliver advanced medical solutions to patients throughout the region.

Stephen Tremel, the Business Operations Chief Financial Officer & Vice President at Johnson & Johnson Services Inc, architects the financial framework supporting global business operations. Overseeing the fiscal health of core operational units, the Business Operations Chief Financial Officer & Vice President ensures that resource deployment aligns with the strategic goals of the medical technology and pharmaceutical sectors. This leadership role involves streamlining internal processes to reduce overhead and improve profit margins. By monitoring global supply chain costs, Stephen Tremel drives efficiency across manufacturing and distribution channels. The Business Operations Chief Financial Officer & Vice President collaborates with cross-functional teams to evaluate the financial viability of new product launches. Through rigorous data analysis and performance reporting, the Business Operations Chief Financial Officer & Vice President maintains transparency and accountability. Ultimately, Tremel optimizes the financial infrastructure to support the company's mission of providing high-quality healthcare products to a global patient base.

Daniel Foo, the Director, Finance (Surgery) & Chief Financial Officer, Medtech Anz at Johnson & Johnson Services Inc, manages the financial operations for the surgery division within the Australia and New Zealand markets. Overseeing regional fiscal planning, the Director, Finance (Surgery) & Chief Financial Officer, Medtech Anz ensures that medical technology investments align with local healthcare needs and corporate profitability targets. This leadership role involves analyzing surgical product performance and market penetration to optimize regional revenue. By implementing cost-management strategies, Daniel Foo drives operational efficiency across the Medtech Anz business unit. The Director, Finance (Surgery) & Chief Financial Officer, Medtech Anz collaborates with regional leadership to forecast growth and allocate resources effectively. Through detailed financial modeling and risk assessment, the Director, Finance (Surgery) & Chief Financial Officer, Medtech Anz supports the expansion of surgical solutions in the region. Ultimately, Foo ensures the financial sustainability of the company's medical technology operations in the Australia and New Zealand markets.

Ryu Shiina, the Chief Financial Officer (APAC) & Heart Recovery & of Abiomed Board Member (Japan) at Johnson & Johnson Services Inc, directs financial strategy for the Asia Pacific region with a specific focus on heart recovery technologies. Overseeing the fiscal health of the Abiomed business in Japan, the Chief Financial Officer (APAC) & Heart Recovery & of Abiomed Board Member (Japan) ensures that cardiovascular care initiatives receive robust financial support. This leadership role involves managing regional budgets and evaluating investment opportunities in medical devices. By optimizing financial performance, Ryu Shiina drives growth in the heart recovery sector across the APAC region. The Chief Financial Officer (APAC) & Heart Recovery & of Abiomed Board Member (Japan) collaborates with the Board to oversee governance and strategic direction in the Japanese market. Through rigorous financial oversight, the Chief Financial Officer (APAC) & Heart Recovery & of Abiomed Board Member (Japan) supports the delivery of advanced cardiovascular solutions. Ultimately, Shiina secures the resources necessary to improve patient outcomes in heart recovery.

Andre Muller, the Executive Vice President & Chief Financial Officer at Johnson & Johnson Services Inc, manages the global financial strategy and capital allocation for the entire organization. Overseeing financial reporting, treasury, and tax functions, the Executive Vice President & Chief Financial Officer ensures that the company maintains a strong balance sheet to support long-term research and development. This leadership role involves coordinating with the CEO to define the financial roadmap for the company's pharmaceutical and medical technology divisions. By implementing enterprise-wide financial controls, Andre Muller drives operational efficiency and shareholder value. The Executive Vice President & Chief Financial Officer collaborates with global business units to monitor performance and mitigate financial risks. Through strategic planning and investment analysis, the Executive Vice President & Chief Financial Officer supports the company's mission to innovate in healthcare. Ultimately, Muller secures the financial foundation that enables the development of life-saving medicines and surgical technologies for patients worldwide.

Dominic Allocco, the Vice President and Associate Chief Marketing Officer at Johnson & Johnson Services Inc, designs and executes global marketing strategies for the company's diverse portfolio of medical devices and pharmaceuticals. Overseeing brand positioning and market engagement, the Vice President and Associate Chief Marketing Officer ensures that healthcare providers understand the clinical value of surgical products and innovative medicines. This leadership role involves analyzing market data to identify growth opportunities in oncology and neuroscience. By developing targeted communication campaigns, Dominic Allocco drives product adoption and strengthens the company's reputation among medical professionals. The Vice President and Associate Chief Marketing Officer collaborates with sales teams to align promotional activities with regional market demands. Through strategic brand management, the Vice President and Associate Chief Marketing Officer enhances the visibility of the company's medical technologies. Ultimately, Allocco expands the reach of the organization's life-enhancing solutions by effectively communicating the benefits of advanced healthcare innovations to global audiences.

Keith McKune, the Senior Scientist & Chief Revenue Officer, Analytical (Release & Stability ) at Johnson & Johnson Services Inc, directs the analytical processes essential for product quality and regulatory compliance. Overseeing the release and stability testing of pharmaceuticals, the Senior Scientist & Chief Revenue Officer, Analytical (Release & Stability ) ensures that every product meets rigorous safety standards before reaching the market. This leadership role involves managing laboratory operations and technical teams to maintain high throughput and accuracy. By optimizing analytical workflows, Keith McKune drives revenue growth through the timely delivery of high-quality medical products. The Senior Scientist & Chief Revenue Officer, Analytical (Release & Stability ) collaborates with quality assurance departments to mitigate risks and ensure adherence to global health regulations. Through technical expertise and operational oversight, the Senior Scientist & Chief Revenue Officer, Analytical (Release & Stability ) supports the company's commitment to patient safety. Ultimately, McKune secures the integrity of the product pipeline, ensuring consistent availability of critical medicines.

Danielle Gomes, the Chief Information Officer, J & J Medtech LATAM at Johnson & Johnson Services Inc, directs the digital transformation and information technology strategy for the medical technology division in Latin America. Overseeing the implementation of advanced data systems, the Chief Information Officer, J & J Medtech LATAM ensures that regional operations leverage technology to improve efficiency and patient care. This leadership role involves managing IT infrastructure and cybersecurity protocols to protect sensitive healthcare data. By integrating digital tools into the supply chain and sales processes, Danielle Gomes drives operational agility across the LATAM region. The Chief Information Officer, J & J Medtech LATAM collaborates with global IT teams to standardize systems and support the company's digital health initiatives. Through strategic investment in technology, the Chief Information Officer, J & J Medtech LATAM enhances the company's ability to deliver innovative medical solutions. Ultimately, Gomes optimizes the digital landscape to support the company's growth and service delivery in Latin America.

Antonio Darpino, the Vice President, Operation & Chief Information Officer at Johnson & Johnson Services Inc, manages the intersection of operational excellence and information technology. Overseeing the integration of digital systems into manufacturing and distribution, the Vice President, Operation & Chief Information Officer ensures that the company's operational infrastructure remains scalable and secure. This leadership role involves directing IT initiatives that support the production of pharmaceuticals and medical devices. By optimizing data flow and system connectivity, Antonio Darpino drives efficiency across the global supply chain. The Vice President, Operation & Chief Information Officer collaborates with business unit leaders to implement technology solutions that enhance productivity and quality control. Through strategic oversight of both operational and digital assets, the Vice President, Operation & Chief Information Officer supports the company's mission to provide high-quality healthcare products. Ultimately, Darpino strengthens the company's operational backbone, ensuring the reliable delivery of medical innovations to patients globally.